Background and purposeDisappointing outcomes from clinical trials involving amyloid-modifying therapies for Alzheimer's disease (AD) have prompted more focus on the concept of early-stage (E) amnestic mild cognitive impairment (E-aMCI). However, limited evidence suggests that E-aMCI may represent aMCI at a very early stage of AD. Furthermore, the nature of the progression of E-aMCI to late-stage aMCI (L-aMCI) remains unclear. Therefore, the aim of the present study was to characterize patterns of cortical thinning in both E-aMCI and L-aMCI patients.MethodsCortical thicknesses were measured in 190 patients with aMCI and 147 subjects with normal cognition. In accordance with memory test scores involving delayed recall items, aMCI patients...
Objective: We investigated differences in regional cortical thickness between previously identified ...
Patients with probable Alzheimer's disease (AD) and the amnesic form of mild cognitive impairmen...
INTRODUCTION: We aimed to investigate if thinner cortex of the Alzheimer's disease (AD)-signature re...
In recent years, amnestic mild cognitive impairment (aMCI) has attracted significant attention as an...
In recent years, amnestic mild cognitive impairment (aMCI) has attracted significant attention as an...
Background: Amnestic Mild cognitive impairment (aMCI) is considered to be the transitional stage bet...
Ministry of Health and Welfare, Republic of KoreaEarly-onset Alzheimer's disease (EOAD) has been...
Mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia are preceded by a phase of dis...
Early-onset Alzheimer's disease (EOAD) has been shown to progress more rapidly than late-onset Alzhe...
Cross-sectional studies have shown regional differences in cortical thickness between healthy older ...
Background: Alzheimer’s disease (AD) is generally considered to be characterized by pathology in gra...
The biological mechanisms that link Beta-amyloid (Aβ) plaque deposition, neurodegeneration, and clin...
Although patients with amnestic mild cognitive impairment (aMCI) are at higher risk of developing Al...
AbstractMild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia are preceded by a phas...
<b><i>Background:</i></b> Amnestic mild cognitive impairment (aMCI) is regarded as a prodromal stage...
Objective: We investigated differences in regional cortical thickness between previously identified ...
Patients with probable Alzheimer's disease (AD) and the amnesic form of mild cognitive impairmen...
INTRODUCTION: We aimed to investigate if thinner cortex of the Alzheimer's disease (AD)-signature re...
In recent years, amnestic mild cognitive impairment (aMCI) has attracted significant attention as an...
In recent years, amnestic mild cognitive impairment (aMCI) has attracted significant attention as an...
Background: Amnestic Mild cognitive impairment (aMCI) is considered to be the transitional stage bet...
Ministry of Health and Welfare, Republic of KoreaEarly-onset Alzheimer's disease (EOAD) has been...
Mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia are preceded by a phase of dis...
Early-onset Alzheimer's disease (EOAD) has been shown to progress more rapidly than late-onset Alzhe...
Cross-sectional studies have shown regional differences in cortical thickness between healthy older ...
Background: Alzheimer’s disease (AD) is generally considered to be characterized by pathology in gra...
The biological mechanisms that link Beta-amyloid (Aβ) plaque deposition, neurodegeneration, and clin...
Although patients with amnestic mild cognitive impairment (aMCI) are at higher risk of developing Al...
AbstractMild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia are preceded by a phas...
<b><i>Background:</i></b> Amnestic mild cognitive impairment (aMCI) is regarded as a prodromal stage...
Objective: We investigated differences in regional cortical thickness between previously identified ...
Patients with probable Alzheimer's disease (AD) and the amnesic form of mild cognitive impairmen...
INTRODUCTION: We aimed to investigate if thinner cortex of the Alzheimer's disease (AD)-signature re...